Virtual Network's Login.
Chairs: M. Cazzola (Pavia), P. Fenaux (Paris), E. Hellström-Lindberg (Stockholm)
Local Organiser: A. Almeida (Lisbon)
SESSION I: EPIDEMIOLOGY AND ETIOLOGY OF MDS
Epidemiology of MDS and environmental factors – D. Bowen
Germline mutations predisposing to MDS – B. Schlegelberger
SESSION II: GENETICS AND EPIGENETICS OF MDS
Myelodysplastic stem cells– P. Woll
SESSION III: 2014 DIAGNOSTIC WORK-UP OF MDS
Cytogenetics – G. Göhring
Flow Cytometry in the Diagnostic Work-up of Myelodysplastic Syndromes – T. Westers
Molecular Biology – T. Haferlach
SESSION IV: CLINICAL PRESENTATION AND RISK ASSESSMENT IN MDS
Prognosis and risk assessment – L. Malcovati
Predictive factors for response to treatment – R. Itzykson
SESSION V: MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS
SESSION VII: ERYTHROPOIESIS & IRON METABOLISM
Pathophysiology and treatment of anaemia in MDS – E. Hellström-Lindberg
SESSION VIII: TREATMENT OF MDS
Management of MDS with del(5q) – M. Jädersten
High risk MDS – L. Ades
Allogeneic HSCT – T. De Witte
Experimental transplantation approaches – N. Kröger
